CStone Pharmaceuticals (HKG:2616)

Hong Kong · Delayed Price · Currency is HKD

8.69

+0.12 (1.40%)

May 7, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals			463.84M	481.36M	243.72M	1.04B		12.55M
Pharmaceuticals Growth			-3.64%	97.51%	-76.54%	-		21.84%
Total			463.84M	481.36M	243.72M	1.04B		12.55M
Total Growth			-3.64%	97.51%	-76.54%	-		21.84%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China			370.23M	-	-	4.72M		-
Outside Mainland China			93.61M	-	-	-		-
PRC (Excluding Hong Kong and Taiwan)			-	476.53M	243.72M	-		12.55M
PRC (Excluding Hong Kong and Taiwan) Growth			-	95.52%	-	-		21.84%
Others			-	4.84M	-	-		-
United States of America			-	-	-	1.03B		-
Total			463.84M	481.36M	243.72M	1.04B		12.55M
Total Growth			-3.64%	97.51%	-76.54%	-		21.84%

Source: S&P Global Market Intelligence.